182 related articles for article (PubMed ID: 31504212)
1. Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson's disease: an in vivo11C-BU99008 PET study.
Wilson H; Dervenoulas G; Pagano G; Tyacke RJ; Polychronis S; Myers J; Gunn RN; Rabiner EA; Nutt D; Politis M
Brain; 2019 Oct; 142(10):3116-3128. PubMed ID: 31504212
[TBL] [Abstract][Full Text] [Related]
2. Imaging imidazoline-I2 binding sites in porcine brain using 11C-BU99008.
Kealey S; Turner EM; Husbands SM; Salinas CA; Jakobsen S; Tyacke RJ; Nutt DJ; Parker CA; Gee AD
J Nucl Med; 2013 Jan; 54(1):139-44. PubMed ID: 23223380
[TBL] [Abstract][Full Text] [Related]
3. Change in the Binding of [
Kawamura K; Yamasaki T; Zhang Y; Wakizaka H; Hatori A; Xie L; Fujinaga M; Zhang MR
Mol Imaging Biol; 2019 Feb; 21(1):105-112. PubMed ID: 29736564
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of
Tyacke RJ; Myers JFM; Venkataraman A; Mick I; Turton S; Passchier J; Husbands SM; Rabiner EA; Gunn RN; Murphy PS; Parker CA; Nutt DJ
J Nucl Med; 2018 Oct; 59(10):1597-1602. PubMed ID: 29523627
[TBL] [Abstract][Full Text] [Related]
5. Astrogliosis in aging and Parkinson's disease dementia: a new clinical study with
Mohamed MA; Zeng Z; Gennaro M; Lao-Kaim NP; Myers JFM; Calsolaro V; Femminella GD; Tyacke RJ; Martin-Bastida A; Gunn RN; Nutt DJ; Edison P; Piccini P; Roussakis AA
Brain Commun; 2022; 4(5):fcac199. PubMed ID: 36072646
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 11C-BU99008, a PET ligand for the imidazoline2 binding sites in rhesus brain.
Parker CA; Nabulsi N; Holden D; Lin SF; Cass T; Labaree D; Kealey S; Gee AD; Husbands SM; Quelch D; Carson RE; Nutt DJ; Huang Y; Tyacke RJ
J Nucl Med; 2014 May; 55(5):838-44. PubMed ID: 24711648
[TBL] [Abstract][Full Text] [Related]
7. Relationship between astrocyte reactivity, using novel
Livingston NR; Calsolaro V; Hinz R; Nowell J; Raza S; Gentleman S; Tyacke RJ; Myers J; Venkataraman AV; Perneczky R; Gunn RN; Rabiner EA; Parker CA; Murphy PS; Wren PB; Nutt DJ; Matthews PM; Edison P
Mol Psychiatry; 2022 Apr; 27(4):2019-2029. PubMed ID: 35125495
[TBL] [Abstract][Full Text] [Related]
8. A useful PET probe [
Kawamura K; Shimoda Y; Yui J; Zhang Y; Yamasaki T; Wakizaka H; Hatori A; Xie L; Kumata K; Fujinaga M; Ogawa M; Kurihara Y; Nengaki N; Zhang MR
Nucl Med Biol; 2017 Feb; 45():1-7. PubMed ID: 27835825
[TBL] [Abstract][Full Text] [Related]
9. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
Wilson H; Dervenoulas G; Pagano G; Koros C; Yousaf T; Picillo M; Polychronis S; Simitsi A; Giordano B; Chappell Z; Corcoran B; Stamelou M; Gunn RN; Pellecchia MT; Rabiner EA; Barone P; Stefanis L; Politis M
Lancet Neurol; 2019 Aug; 18(8):748-759. PubMed ID: 31229470
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline₂ binding site.
Tyacke RJ; Fisher A; Robinson ES; Grundt P; Turner EM; Husbands SM; Hudson AL; Parker CA; Nutt DJ
Synapse; 2012 Jun; 66(6):542-51. PubMed ID: 22290740
[TBL] [Abstract][Full Text] [Related]
11. Astroglial tracer BU99008 detects multiple binding sites in Alzheimer's disease brain.
Kumar A; Koistinen NA; Malarte ML; Nennesmo I; Ingelsson M; Ghetti B; Lemoine L; Nordberg A
Mol Psychiatry; 2021 Oct; 26(10):5833-5847. PubMed ID: 33888872
[TBL] [Abstract][Full Text] [Related]
12. Cortical thinning across Parkinson's disease stages and clinical correlates.
Wilson H; Niccolini F; Pellicano C; Politis M
J Neurol Sci; 2019 Mar; 398():31-38. PubMed ID: 30682518
[TBL] [Abstract][Full Text] [Related]
13. Astrocyte reactivity with late-onset cognitive impairment assessed in vivo using
Calsolaro V; Matthews PM; Donat CK; Livingston NR; Femminella GD; Guedes SS; Myers J; Fan Z; Tyacke RJ; Venkataraman AV; Perneczky R; Gunn R; Rabiner EA; Gentleman S; Parker CA; Murphy PS; Wren PB; Hinz R; Sastre M; Nutt DJ; Edison P
Mol Psychiatry; 2021 Oct; 26(10):5848-5855. PubMed ID: 34267329
[No Abstract] [Full Text] [Related]
14. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
[TBL] [Abstract][Full Text] [Related]
15. Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study.
Hu MT; Taylor-Robinson SD; Chaudhuri KR; Bell JD; Labbé C; Cunningham VJ; Koepp MJ; Hammers A; Morris RG; Turjanski N; Brooks DJ
Brain; 2000 Feb; 123 ( Pt 2)():340-52. PubMed ID: 10648441
[TBL] [Abstract][Full Text] [Related]
16. Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study.
Horsager J; Andersen KB; Knudsen K; Skjærbæk C; Fedorova TD; Okkels N; Schaeffer E; Bonkat SK; Geday J; Otto M; Sommerauer M; Danielsen EH; Bech E; Kraft J; Munk OL; Hansen SD; Pavese N; Göder R; Brooks DJ; Berg D; Borghammer P
Brain; 2020 Oct; 143(10):3077-3088. PubMed ID: 32830221
[TBL] [Abstract][Full Text] [Related]
17. Imidazoline-I2 PET Tracers in Neuroimaging.
Parker CA; Nutt DJ; Tyacke RJ
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372936
[TBL] [Abstract][Full Text] [Related]
18. Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease.
Niccolini F; Foltynie T; Reis Marques T; Muhlert N; Tziortzi AC; Searle GE; Natesan S; Kapur S; Rabiner EA; Gunn RN; Piccini P; Politis M
Brain; 2015 Oct; 138(Pt 10):3003-15. PubMed ID: 26210536
[TBL] [Abstract][Full Text] [Related]
19. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease.
Gerhard A; Pavese N; Hotton G; Turkheimer F; Es M; Hammers A; Eggert K; Oertel W; Banati RB; Brooks DJ
Neurobiol Dis; 2006 Feb; 21(2):404-12. PubMed ID: 16182554
[TBL] [Abstract][Full Text] [Related]
20. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
